Aura Biosciences reported total assets of $321.62M and total liabilities of $34.19M for the quarter ended Sep 2026, up 69.3% year over year. This balance sheet covers 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 149.06M | 108.38M | 53.85M | 61.11M | 121.58M | 38.49M | 47.73M | 55.58M | 41.06M | 26.28M | 30.08M | 25.41M | 31.69M | 38.23M | 107.37M | 47.55M | 59.52M | 84.79M | 67.84M | 41.67M | |||||
| Cash & Current Investments | 149.06M | 108.38M | 53.85M | 61.11M | 121.58M | 38.49M | 47.73M | 55.58M | 41.06M | 26.28M | 30.08M | 25.41M | 31.69M | 38.23M | 107.37M | 47.55M | 59.52M | 84.79M | 67.84M | 41.67M | |||||
| Prepaid Assets | 4.62M | 6.28M | 5.51M | 4.21M | 7.87M | 5.58M | 4.18M | 4.81M | 5.63M | 9.38M | 8.18M | 9.10M | 9.53M | 6.53M | 6.65M | 8.25M | 5.50M | 3.77M | 5.19M | 5.87M | |||||
| Current Assets | 153.70M | 139.58M | 127.67M | 115.91M | 196.70M | 179.12M | 166.21M | 153.89M | 231.79M | 212.25M | 195.60M | 183.48M | 160.62M | 134.52M | 183.96M | 170.12M | 149.74M | 118.50M | 329.03M | 303.10M | |||||
| Non-Current Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 5.25M | 5.91M | 5.80M | 5.48M | 5.37M | 5.17M | 5.06M | 4.86M | 3.15M | 3.05M | 3.33M | 3.33M | 3.22M | 3.11M | 2.86M | 2.63M | 2.62M | 2.47M | 2.20M | 2.02M | |||||
| Other Non-Current Assets | 0.13M | 0.13M | 0.89M | 0.77M | 1.19M | 0.77M | 0.77M | 0.77M | 1.28M | 0.77M | 0.77M | 0.77M | 1.29M | 0.77M | 0.77M | 0.77M | 1.24M | 1.29M | 1.91M | 1.94M | |||||
| Non-Current Assets | 6.33M | 6.84M | 7.35M | 27.24M | 27.23M | 26.90M | 26.53M | 25.88M | 23.28M | 22.78M | 22.69M | 21.86M | 21.88M | 20.88M | 20.44M | 19.90M | 19.69M | 19.17M | 19.10M | 18.52M | |||||
| Assets | 160.03M | 146.42M | 135.02M | 143.15M | 223.94M | 206.02M | 192.74M | 179.77M | 255.08M | 235.03M | 218.28M | 205.34M | 182.50M | 155.40M | 204.40M | 190.02M | 169.43M | 137.68M | 348.13M | 321.62M | |||||
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payables | 2.40M | 1.96M | 1.20M | 1.72M | 2.92M | 1.06M | 0.55M | 1.49M | 1.79M | 1.93M | 1.46M | 1.99M | 2.30M | 2.01M | 1.29M | 1.89M | 1.55M | 2.57M | 2.25M | 1.72M | |||||
| Payables | 2.40M | 1.96M | 1.20M | 1.72M | 2.92M | 1.06M | 0.55M | 1.49M | 1.79M | 1.93M | 1.46M | 1.99M | 2.30M | 2.01M | 1.29M | 1.89M | 1.55M | 2.57M | 2.25M | 1.72M | |||||
| Accumulated Expenses | 4.34M | 2.42M | 3.98M | 5.30M | 4.57M | 4.07M | 5.33M | 6.37M | 7.88M | 4.99M | 6.34M | 9.60M | 9.46M | 6.99M | 10.37M | 13.72M | 13.59M | 10.87M | 14.01M | 16.30M | |||||
| Other Accumulated Expenses | 1.69M | 1.05M | 1.59M | 2.19M | 1.54M | 2.22M | 2.47M | 2.43M | 3.45M | 2.51M | 2.30M | 4.17M | 3.39M | 3.36M | 5.45M | 7.14M | 7.01M | 7.54M | 8.26M | 8.04M | |||||
| Current Leases | |||||||||||||||||||||||||
| Current Taxes | |||||||||||||||||||||||||
| Total Current Liabilities | 7.36M | 5.00M | 5.81M | 9.96M | 10.46M | 8.11M | 8.90M | 10.89M | 12.36M | 9.66M | 10.55M | 14.71M | 14.91M | 12.16M | 14.85M | 18.82M | 18.38M | 16.71M | 19.56M | 21.34M | |||||
| Non-Current Liabilities | |||||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||
| Operating Leases | 0.36M | 0.21M | 0.05M | 18.13M | 17.90M | 17.65M | 17.41M | 17.15M | 16.87M | 16.58M | 16.28M | 15.96M | 15.62M | 15.27M | 14.92M | 14.53M | 14.13M | 13.72M | 13.30M | 12.85M | |||||
| Other Non-Current Liabilities | 0.08M | 0.13M | 0.07M | ||||||||||||||||||||||
| Total Non-Current Liabilities | 7.63M | 5.21M | 5.86M | ||||||||||||||||||||||
| Total Liabilities | 7.72M | 5.34M | 5.93M | 28.09M | 28.35M | 25.76M | 26.30M | 28.05M | 29.23M | 26.24M | 26.83M | 30.67M | 30.53M | 27.44M | 29.77M | 33.36M | 32.52M | 30.43M | 32.86M | 34.19M | |||||
| Shareholder's Equity | |||||||||||||||||||||||||
| Common Equity | 152.32M | 141.09M | 129.09M | 115.05M | 195.58M | 180.26M | 166.44M | 151.72M | 225.85M | 208.78M | 191.45M | 174.67M | 151.97M | 127.97M | 174.63M | 156.67M | 136.91M | 107.25M | 315.27M | 287.43M | |||||
| Liabilities and Shareholders Equity | 160.03M | 146.42M | 135.02M | 143.15M | 223.94M | 206.02M | 192.74M | 179.77M | 255.08M | 235.03M | 218.28M | 205.34M | 182.50M | 155.40M | 204.40M | 190.02M | 169.43M | 137.68M | 348.13M | 321.62M | |||||
| Treasury Stock | 39.10M | 39.10M | |||||||||||||||||||||||
| Retained Earnings | -152.14M | -165.00M | -178.44M | -194.34M | -210.90M | -228.40M | -246.70M | -265.20M | -287.31M | -307.01M | -327.35M | -348.39M | -374.23M | -401.71M | -428.73M | -454.86M | -480.42M | -514.10M | -559.74M | -591.81M | |||||
| Treasury Shares | 6.92M | 6.92M |
Pull Aura Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=AURA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "AURA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=AURA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();